Stock-Based Compensation (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Fair Value of the Options

The following inputs were used to calculate the fair value of the options as of the date of each grant:

	Years ended December 31,
	2022		2021
Expected volatility		36.7 – 36.9%		52.5 – 52.9%
Expected term (years)		4.69 – 4.94		6.25
Risk-free interest rate		4.03% – 4.06%		1.08% – 1.46%
Expected dividends		0.00%		0.00%

Schedule of Options Outstanding

The following table summarizes options outstanding, as well as activity for the periods presented (prior year amounts have been converted using the conversion ratio of 14.2069 applied in the Business Combination):

				Weighted		Weighted
				Average		Average		Aggregate
				Grant Date		Exercise		Intrinsic
	Options			Fair Value		Price		Value
Outstanding as of December 31, 2021		3,947,359		$	0.91	$	1.74	$	2,992,895
Granted		166,931		$	1.31	$	2.49
Cancelled		(146,331	)	$	1.15	$	2.25
Outstanding as of June 30, 2022		3,967,959		$	0.87	$	1.85	$	2,577,625
Outstanding as of December 31, 2022		3,503,601		$	1.87	$	1.87	$	6,554,541
Exercised		(179,236	)	$	2.09	$	1.91
Forfeited		(42,614	)	$	1.02	$	2.03
Cancelled		(5,408	)	$	1.94	$	1.94
Outstanding as of June 30, 2023		3,276,343		$	1.89	$	1.87	$	3,673,399

The following table summarizes options outstanding, as well as activity for the periods presented

	Shares			Weighted Average Grant Date Fair Value		Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding as of December 31, 2020		2,345,559		$	0.77	$	1.59	$	779,457
Granted		1,726,488		$	1.10	$	1.94
Exercised		(31,255	)	$	0.47	$	1.13
Cancelled		(91,634	)	$	0.78	$	1.88
Outstanding as of December 31, 2021		3,949,158		$	0.91	$	1.74	$	2,992,895
Granted		166,927		$	1.31	$	2.50
Cancelled		(609,901	)	$	0.83	$	1.83
Outstanding as of December 31, 2022		3,506,184		$	1.87	$	1.87	$	6,554,541

Schedule of Outstanding and Exercisable Options

The following tabulation summarizes certain information related to outstanding and exercisable options at December 31, 2022:

				Options Outstanding						Options Exercisable
Range of Exercise Prices				As of December 31, 2022		Weighted Average Remaining Contractual Life In Years		Weighted Average Exercise Price		As of December 31, 2022		Weighted Average Exercise Price
$	0.63	$	0.70		284,137		3.02	$	0.65		284,137	$	0.65
$	1.13	$	1.46		473,796		6.01	$	1.29		370,618	$	1.25
$	1.94	$	2.50		2,748,251		7.61	$	2.10		1,444,609	$	2.03
$	0.63	$	2.50		3,506,184		7.02	$	1.87		2,099,364	$	1.70

Schedule of Restricted and Performance Stock Unit Activity

The following is a summary of our RSU and PRSU activity for the first six months of 2023:

				Weighted
				Average		Aggregate
				Grant Date		Intrinsic
	Shares			Fair Value		Value
Outstanding as of December 31, 2022		3,134,677		$	4.73
Awarded		246,123		$	2.76
Released		(298,531	)	$	4.26
Forfeited		(72,636	)	$	4.73
Outstanding as of June 30, 2023		3,009,633		$	4.61	$	8,953,659

The following is a summary of our restricted and performance stock unit activity for 2022:

	Shares			Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding as of December 31, 2021		—		$	0.00
Awarded		3,149,800		$	4.73
Forfeited		(15,123	)	$	4.73
Outstanding as of December 31, 2022		3,134,677		$	4.73	$	11,723,692